Hi Elektra,
here's some more items I found in my bookmarks:
Click on picture to enlarge:
source:
Medscape: Medscape Access
Quote:
|
In cases of severe borderline personality disorder, it is common to combine the use of medication with psychodynamic psychotherapy, as suggested by the American Psychiatric Association practice guideline on the disorder (26). While a variety of psychopharmacologic agents appear to be useful for patients with borderline personality disorder, the selective serotonin reuptake inhibitors (SSRIs) have garnered supportive data in four double-blind placebo-controlled trials (15, 27—29). SSRIs may facilitate therapy by reducing the intense anger, dysphoria, and hypervigilant anxiety connected with the patient’s internal object world (20). Rinne et al. (30) noted that fluvoxamine is associated with a significant reduction of ACTH and cortisol response in borderline patients, particularly in those who sustained childhood abuse. It may well be that toning down the hyperreactivity of the HPA axis with an SSRI moderates the patient’s specific object-relations unit of victimized, hypervigilant self linked to a potentially malevolent object. The diminution of the hypervigilant anxiety promotes greater reflective capacity, allowing the patient to consider what is going on in the therapeutic relationship more effectively (20).
|
source:
PsychiatryOnline | FOCUS: The Journal of Lifelong Learning in Psychiatry | Psychodynamic Approaches to Personality Disorders strategies and evidence